loader
Please Wait
Applying Filters...

Find excipient solutions to address Emedastine formulation challenges (e.g. drug delivery, bioavailability, taste masking, controlled release, solubility, stability etc).

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Gangwal Healthcare

02 1Pfanstiehl

03 1ACG Worldwide

04 7Actylis

05 2Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

06 2BioSpectra

07 20Corel Pharma Chem

08 2Finar

09 6Gangwal Chemicals

10 4Ideal Cures Pvt Ltd

11 14Kerry

12 4Kima Chemical

13 6Lonza Capsugel

14 1Microlex e.U

15 1Novo Excipients

16 1Qianhao Chemical (Hebei) Co., Ltd

17 1Qualicaps

18 11Seppic

19 2Shanghai Shenmei Pharmaceutical Technology Co., Ltd

20 3The Dow Chemical Company

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

Grade : Parenteral

Brand Name : Tris Base

Excipient Details : Tris (hydroxymethyl) aminomethane is used in electrophoresis, protein purification, enzyme assay, and as a buffering agent in biologics production.

Pharmacopoeia Ref : USP, EP, BP, ChP

Technical Specs : pH: 7 and 9

Grade : Parenteral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

Dosage Form : Injectable / Parenteral

Category : Parenteral

Brand : TRIS BASE

Applications : Tris (hydroxymethyl) aminomethane is used in electrophoresis, protein purification, enzyme assay, and as a buffering agent in biologics production.

Pharmacopoeia Ref : USP, EP, BP, ChP

Technical Specs : pH: 7 and 9

Grade : Parenteral

arrow

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

05

arrow
2024 ACI Convention
Not Confirmed

09

arrow
2024 ACI Convention
Not Confirmed

14

arrow
2024 ACI Convention
Not Confirmed

15

arrow
2024 ACI Convention
Not Confirmed

19

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

20

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

25

arrow
2024 ACI Convention
Not Confirmed

29

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : ZEPHYR™

Applications : The number of inhalation formulas for nasal and pulmonary drug delivery continues to grow, driven by the prevalence of respiratory diseases. Capsugel® offers inhalation drug-delivery capabilities for inhalable powder medication.

Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vegetarian Society, Halal and Kosher certifications

Technical Specs : Size # 00el - 4

Grade : Inhalation

arrow
blank

31

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

34

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

35

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Vcaps® Plus

Excipient Details : An immediate-release HPMC capsule without gelling agents. Vcaps® Plus offer excellent dissolution profile with pH-independent performance, standard or low-moisture content, great machinability and visual quality.

Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...

Technical Specs : "Water content – less than 9%, can be customized; Size # 00el - 4

Grade : Oral and Inhalation

arrow

Brand : VCAPS® PLUS

Applications : An immediate-release HPMC capsule without gelling agents. Vcaps® Plus offer excellent dissolution profile with pH-independent performance, standard or low-moisture content, great machinability and visual quality.

Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vegetarian Society, Halal and Kosher certifications

Technical Specs : "Water content – less than 9%, can be customized; Size # 00el - 4

Grade : Oral and Inhalation

arrow
blank

37

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank

40

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : DRCAPS®

Applications : DRcaps® are made with an innovative HPMC formulation that can help protect sensitive ingredients from the low pH environment of the stomach. The low-moisture level of DRcaps® provides enhanced stability for hygroscopic ingredients.

Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vegetarian Society, Halal and Kosher certifications

Technical Specs : Size # 0-1

Grade : Oral

arrow
blank

45

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® HML C2910

Excipient Details : It is used in film coating of tablets due to its higher molecular weight and higher resistance to simulated gastric fluid, high degree of polymerisation.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...

Technical Specs : Also Available as Microlex® HML C2906, Microlex® HML C2208.

Grade : Oral

arrow

Brand : MICROLEX® HML C2910

Applications : It is used in film coating of tablets due to its higher molecular weight and higher resistance to simulated gastric fluid, high degree of polymerisation.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/JPE

Technical Specs : Also Available as Microlex® HML C2906, Microlex® HML C2208.

Grade : Oral

arrow
blank

51

arrow
2024 ACI Convention
Not Confirmed